(8S,11S,14S,17R,20S)-20-((1H-imidazol-4-yl)methyl)-11-((1H-indol-3-yl)methyl)-14-(3-guanidinopropyl)-17-(naphthalen-2-ylmethyl)-6,10,13,16,19,22-hexaoxo-5,9,12,15,18,21-hexaazaspiro[3.18]docosane-8-carboxamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (8S,11S,14S,17R,20S)-20-((1H-imidazol-4-yl)methyl)-11-((1H-indol-3-yl)methyl)-14-(3-guanidinopropyl)-17-(naphthalen-2-ylmethyl)-6,10,13,16,19,22-hexaoxo-5,9,12,15,18,21-hexaazaspiro[3.18]docosane-8-carboxamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(8S,11S,14S,17R,20S)-20-((1H-imidazol-4-yl)methyl)-11-((1H-indol-3-yl)methyl)-14-(3-guanidinopropyl)-17-(naphthalen-2-ylmethyl)-6,10,13,16,19,22-hexaoxo-5,9,12,15,18,21-hexaazaspiro[3.18]docosane-8-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Melanocortin receptor 3 Protein (Entity type)	EC50
	(8S,11S,14S,17R,20S)-20-((1H-imidazol-4-yl)methyl)-11-((1H-indol-3-yl)methyl)-14-(3-guanidinopropyl)-17-(naphthalen-2-ylmethyl)-6,10,13,16,19,22-hexaoxo-5,9,12,15,18,21-hexaazaspiro[3.18]docosane-8-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Melanocyte-stimulating hormone receptor Protein (Entity type)	EC50